B and T lymphocyte attenuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of gastroenterology

• Publication date

  2013-03-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00535-013-0762-9PMID 23532637
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1.

  2012cited by this paper
• T-bet represses expression of PD-1 and sustains virus-specific CD8 T cell responses during chronic infection

  2011cited by this paper
• Role of the coinhibitory receptor cytotoxic T lymphocyte antigen‐4 on apoptosis‐Prone CD8 T cells in persistent hepatitis B virus infection

  2011cited by this paper
• Regulation of inflammation, autoimmunity, and infection immunity by HVEM‐BTLA signaling

  2011cited by this paper
• Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.

  2010cited by this paper
• The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus‐specific CD8+ T‐cell function

  2010cited by this paper
• Features of responding T cells in cancer and chronic infection.

  2010cited by this paper
• B and T Lymphocyte Attenuator Is Highly Expressed on CMV-Specific T Cells during Infection and Regulates Their Function

  2010cited by this paper
• Clearance of hepatitis C in chimpanzees is associated with intrahepatic T‐cell perforin expression during the late acute phase

  2010cited by this paper
• How chronic viral infections impact on antigen‐specific T‐cell responses

  2010cited by this paper
• PD‐1/PD‐L1 pathway and T‐cell exhaustion in chronic hepatitis virus infection

  2010cited by this paper
• Cosignaling molecules around LIGHT-HVEM-BTLA: from immune activation to therapeutic targeting.

  2009cited by this paper
• Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection

  2009cited by this paper
• Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection

  2008cited by this paper
• IL-10, T cell exhaustion and viral persistence.

  2007cited by this paper
• Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection

  2007cited by this paper
• Molecular signature of CD8+ T cell exhaustion during chronic viral infection.

  2007cited by this paper
• Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion

  2007cited by this paper
• The T-box transcription factor T-bet in immunity and autoimmunity.

  2006cited by this paper
• Balancing co-stimulation and inhibition with BTLA and HVEM

  2006cited by this paper
• PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

  2006cited by this paper
• B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator

  2005cited by this paper
• Immunology of hepatitis B virus and hepatitis C virus infection

  2005cited by this paper
• A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.

  2005cited by this paper
• Longitudinal Analysis of CD8+ T Cells Specific for Structural and Nonstructural Hepatitis B Virus Proteins in Patients with Chronic Hepatitis B: Implications for Immunotherapy

  2004cited by this paper
• Kinetics of the immune response during HBV and HCV infection

  2003cited by this paper
• Cytokines and Transcription Factors That Regulate T Helper Cell Differentiation: New Players and New Insights

  2003cited by this paper
• Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2.

  2003cited by this paper
• Human CD8+ T-cell differentiation in response to viruses

  2003cited by this paper
• Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment

  2003cited by this paper
• BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

  2003cited by this paper
• Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

  2002cited by this paper
• The Role of Virus-Specific Cd8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection

  2000cited by this paper
• The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection.

  2000cited by this paper

• A Systematic Review of the Advances in the Study of T Lymphocyte Suppressor Receptors in HBV Infection: Potential Therapeutic Targets

  2024cites this paper
• Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC

  2024cites this paper
• Insights into Immune Exhaustion in Chronic Hepatitis B: A Review of Checkpoint Receptor Expression

  2024cites this paper
• BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4+ T-cell exhaustion

  2024cites this paper
• Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy

  2023cites this paper
• The CD8+ T cell exhaustion mechanisms in chronic hepatitis B infection and immunotherapeutic strategies: a systematic review

  2023influential citation
• A lipid metabolism–based prognostic risk model for HBV–related hepatocellular carcinoma

  2023cites this paper
• Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation

  2023cites this paper
• The role of the BTLA-HVEM complex in the pathogenesis of autoimmune diseases.

  2022cites this paper
• Highlighting novel targets in immunotherapy for liver cancer

  2022cites this paper
• Roles of BTLA in Immunity and Immune Disorders

  2021influential citation
• Immune Checkpoints in Viral Infections

  2020cites this paper
• Identification of potential mRNA panels for severe acute respiratory syndrome coronavirus 2 (COVID-19) diagnosis and treatment using microarray dataset and bioinformatics methods

  2020cites this paper
• Expression and clinical significance of B and T lymphocyte attenuator on CD4+ and CD8+ T cells from patients with pulmonary tuberculosis

  2019cites this paper
• BTLA/HVEM Signaling: Milestones in Research and Role in Chronic Hepatitis B Virus Infection

  2019cites this paper
• The Influence of B and T Lymphocyte Attenuator Genetic Variants on Susceptibility to Chronic Hepatitis B Virus Infection

  2018cites this paper
• Hepatic expansion of virus-specific CD8+BTLA+ T cells with regulatory properties in chronic hepatitis B virus infection.

  2017cites this paper
• Chronic hepatitis B: immune pathogenesis and emerging immunotherapeutics.

  2016cites this paper
• Decreased B and T lymphocyte attenuator in Behcet’s disease may trigger abnormal Th17 and Th1 immune responses

  2016cites this paper
• Evolution in Our Understanding of Hepatitis B Virus Virology and Immunology.

  2016cites this paper
• Tumor necrosis factor superfamily in innate immunity and inflammation.

  2015cites this paper
• Expression of PD-L1 on CD4+CD25+Foxp3+ Regulatory T Cells of Patients with Chronic HBV Infection and Its Correlation with Clinical Parameters

  2015cites this paper
• Current status of immunomodulatory therapy in chronic hepatitis B, fifty years after discovery of the virus: Search for the "magic bullet" to kill cccDNA.

  2015cites this paper
• Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer

  2015cites this paper